ArticleiScience2026
Causal and shared genetic insights into severe COVID-19 and idiopathic pulmonary fibrosis.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although the immediate threat of COVID-19 has lessened, survivors of severe disease still face long-term risks. Utilizing publicly available GWAS summary statistics, we conducted PheWAS enrichment across 2,142 phenotypes to ascertain the traits linked to severe COVID-19. Subsequently, we conducted genome-wide cross-trait analyses to explore genetic correlations, pleiotropic loci, and functional annotations. Mendelian randomization (MR) was employed to deduce causality. Idiopathic pulmonary fibrosis (IPF) emerged as a phenotype significantly linked to severe COVID-19 after false discovery rate correction. We identified substantial genetic correlations and 14 shared pleiotropic loci between severe COVID-19 and IPF, encompassing five additional loci that validated nine variants, notably rs34517439. MR and CAUSE analyses substantiated the causal impact of genetic predisposition on IPF in individuals with severe COVID-19. These findings demonstrate a genetic overlap and a causal relationship between IPF and severe COVID-19, enhancing comprehension of the mechanisms and guiding risk stratification and prevention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.